SEARCH

SEARCH BY CITATION

References

  • 1
    Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:17201745.
  • 2
    Hoskins G, McCowan C, Neville RG, Thomas GE, Smith B, Silverman S. Risk factors and costs associated with an asthma attack. Thorax 2000;55:1924.
  • 3
    Lane S, Molina J, Plusa T. An international observational prospective study to determine the cost of asthma exacerbations (COAX). Respir Med 2006;100:434450.
  • 4
    O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med 2009;179:1924.
  • 5
    Martinez FD. The origins of asthma and chronic obstructive pulmonary disease in early life. Proc Am Thorac Soc 2009;6:272277.
  • 6
    Romagnoli M, Caramori G, Braccioni F, Ravenna F, Barreiro E, Siafakas NM et al. Near-fatal asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy 2007;37:552557.
  • 7
    Loymans RJ, Ter Riet G, Sterk PJ. Definitions of asthma exacerbations. Curr Opin Allergy Clin Immunol 2011;11:181186.
  • 8
    Anon. Global Initiative for Obstructive Lung Disease. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. [html] 2010 [cited 2011; Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosismanagement.
  • 9
    Kerrebijn KF, van Essen-Zandvliet EE, Neijens HJ. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol 1987;79:653659.
  • 10
    Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Pineiro A, Wei LX et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999;130:487495.
  • 11
    Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002;109:410418.
  • 12
    Anon. British guideline on the management of asthma: a national clinical guideline. Edinburgh & London, 2008. June, 2009 (Revision).
  • 13
    Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010;126:926938.
  • 14
    Bush A, Zar HJ. WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol 2011;11:115121.
  • 15
    Murphy AC, Proeschal A, Brightling CE, Wardlaw AJ, Pavord I, Bradding P et al. The relationship between clinical outcomes and medication adherence in difficult-to-control asthma. Thorax 2012;67:751753.
  • 16
    Nikander K, Turpeinen M, Pelkonen AS, Bengtsson T, Selroos O, Haahtela T. True adherence with the Turbuhaler in young children with asthma. Arch Dis Child 2011;96:168173.
  • 17
    Gamble J, Stevenson M, McClean E, Heaney LG. The prevalence of nonadherence in difficult asthma. Am J Respir Crit Care Med 2009;180:817822.
  • 18
    Heaney LG, Horne R. Non-adherence in difficult asthma: time to take it seriously. Thorax 2012;67:268270.
  • 19
    Bracken M, Fleming L, Hall P, Van Stiphout N, Bossley C, Biggart E et al. The importance of nurse-led home visits in the assessment of children with problematic asthma. Arch Dis Child 2009;94:780784.
  • 20
    Agache I, Akdis C, Jutel M, Virchow JC. Untangling asthma phenotypes and endotypes. Allergy 2012;67:835846.
  • 21
    Doull IJ, Lampe FC, Smith S, Schreiber J, Freezer NJ, Holgate ST. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomised double blind placebo controlled trial. BMJ 1997;315:858862.
  • 22
    Papadopoulos NG, Arakawa H, Carlsen KH, Custovic A, Gern J, Lemanske R et al. International consensus on (ICON) pediatric asthma. Allergy 2012;67:976997.
  • 23
    Custovic A, Lazic N, Simpson A. Pediatric asthma and development of atopy. Curr Opin Allergy Clin Immunol 2013;13:173180.
  • 24
    Belgrave DCM, Simpson A, Semic-Jusufagic A, Murray CS, Buchan I, Pickles A et al. Joint modeling of parentally-reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing. J Allergy Clin Immunol 2013;132:575583.
  • 25
    Lazic N, Roberts G, Custovic A, Belgrave D, Bishop CM, Winn J et al. Multiple atopy phenotypes and their associations with asthma: similar findings from two birth cohorts. Allergy 2013;68:764770.
  • 26
    Simpson A, Tan VY, Winn J, Svensen M, Bishop CM, Heckerman DE et al. Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med 2010;181:12001206.
  • 27
    ten Brinke A, Sterk PJ, Masclee AA, Spinhoven P, Schmidt JT, Zwinderman AH et al. Risk factors of frequent exacerbations in difficult-to-treat asthma. Eur Respir J 2005;26:812818.
  • 28
    Calam R, Gregg L, Simpson A, Simpson B, Woodcock A, Custovic A. Behavior problems antecede the development of wheeze in childhood: a birth cohort study. Am J Respir Crit Care Med 2005;171:323327.
  • 29
    Veen JC, Smits HH, Ravensberg AJ, Hiemstra PS, Sterk PJ, Bel EH. Impaired perception of dyspnea in patients with severe asthma. Relation to sputum eosinophils. Am J Respir Crit Care Med 1998;158:11341141.
  • 30
    Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360:17151721.
  • 31
    Jayaram L, Pizzichini MM, Cook RJ, Boulet LP, Lemiere C, Pizzichini E et al. Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations. Eur Respir J 2006;27:483494.
  • 32
    Haldar P, Brightling CE, Hargadon B, Gupta S, Monteiro W, Sousa A et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973984.
  • 33
    Nair P, Pizzichini MM, Kjarsgaard M, Inman MD, Efthimiadis A, Pizzichini E et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360:985993.
  • 34
    Gelb AF, Flynn Taylor C, Shinar CM, Gutierrez C, Zamel N. Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics. Chest 2006;129:14921499.
  • 35
    Gibson PG. Using fractional exhaled nitric oxide to guide asthma therapy: design and methodological issues for ASthma TReatment ALgorithm studies. Clin Exp Allergy 2009;39:478490.
  • 36
    Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602615.
  • 37
    Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol 2010;125:11781187; quiz 1188–1179.
  • 38
    Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995;310:12251229.
  • 39
    Papadopoulos NG, Christodoulou I, Rohde G, Agache I, Almqvist C, Bruno A et al. Viruses and bacteria in acute asthma exacerbations–a GA(2) LEN-DARE systematic review. Allergy 2011;66:458468.
  • 40
    Bisgaard H, Hermansen MN, Bonnelykke K, Stokholm J, Baty F, Skytt NL et al. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ 2010;341:c4978.
  • 41
    Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL et al. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax 2006;61:376382.
  • 42
    Green RM, Custovic A, Sanderson G, Hunter J, Johnston SL, Woodcock A. Synergism between allergens and viruses and risk of hospital admission with asthma: case-control study. BMJ 2002;324:763.
  • 43
    Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831834.
  • 44
    Laza-Stanca V, Message SD, Edwards MR, Parker HL, Zdrenghea MT, Kebadze T et al. The role of IL-15 deficiency in the pathogenesis of virus-induced asthma exacerbations. PLoS Pathog 2011;7:e1002114.
  • 45
    Message SD, Laza-Stanca V, Mallia P, Parker HL, Zhu J, Kebadze T et al. Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production. Proc Natl Acad Sci USA 2008;105:1356213567.
  • 46
    Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006;12:10231026.
  • 47
    Jartti T, Lehtinen P, Vanto T, Hartiala J, Vuorinen T, Makela MJ et al. Evaluation of the efficacy of prednisolone in early wheezing induced by rhinovirus or respiratory syncytial virus. Pediatr Infect Dis J 2006;25:482488.
  • 48
    Pilishvili T, Zell ER, Farley MM, Schaffner W, Lynfield R, Nyquist AC et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics 2010;126:e9e17.
  • 49
    Klemets P, Lyytikainen O, Ruutu P, Ollgren J, Kaijalainen T, Leinonen M et al. Risk of invasive pneumococcal infections among working age adults with asthma. Thorax 2010;65:698702.
  • 50
    Talbot TR, Hartert TV, Mitchel E, Halasa NB, Arbogast PG, Poehling KA et al. Asthma as a risk factor for invasive pneumococcal disease. N Engl J Med 2005;352:20822090.
  • 51
    Bosco A, Ehteshami S, Stern DA, Martinez FD. Decreased activation of inflammatory networks during acute asthma exacerbations is associated with chronic airflow obstruction. Mucosal Immunol 2010;3:399409.
  • 52
    Du R, Litonjua AA, Tantisira KG, Lasky-Su J, Sunyaev SR, Klanderman BJ et al. Genome-wide association study reveals class I MHC-restricted T cell-associated molecule gene (CRTAM) variants interact with vitamin D levels to affect asthma exacerbations. J Allergy Clin Immunol 2012;129:368373.
  • 53
    Canova C, Dunster C, Kelly FJ, Minelli C, Shah PL, Caneja C et al. PM10-induced hospital admissions for asthma and chronic obstructive pulmonary disease: the modifying effect of individual characteristics. Epidemiology 2012;23:607615.
  • 54
    Wan YI, Shrine NR, Soler Artigas M, Wain LV, Blakey JD, Moffatt MF et al. Genome-wide association study to identify genetic determinants of severe asthma. Thorax 2012;67:762768.
  • 55
    Xu M, Tantisira KG, Wu A, Litonjua AA, Chu JH, Himes BE et al. Genome Wide Association Study to predict severe asthma exacerbations in children using random forests classifiers. BMC Med Genet 2011;12:90.
  • 56
    Bush A, Saglani S. Management of severe asthma in children. Lancet 2010;376:814825.
  • 57
    Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008;32:10961110.
  • 58
    Bacharier LB, Boner A, Carlsen KH, Eigenmann PA, Frischer T, Gotz M et al. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. Allergy 2008;63:534.
  • 59
    Schultz A, Devadason SG, Savenije OE, Sly PD, Le Souef PN, Brand PL. The transient value of classifying preschool wheeze into episodic viral wheeze and multiple trigger wheeze. Acta Paediatr 2010;99:5660.
  • 60
    Sharples J, Gupta A, Fleming L, Bossley CJ, Bracken-King M, Hall P et al. Long-term effectiveness of a staged assessment for paediatric problematic severe asthma. Eur Respir J 2012;40:264267.
  • 61
    Frith J, Fleming L, Bossley C, Ullmann N, Bush A. The complexities of defining atopy in severe childhood asthma. Clin Exp Allergy 2011;41:948953.
  • 62
    Marinho S, Simpson A, Marsden P, Smith JA, Custovic A. Quantification of atopy, lung function and airway hypersensitivity in adults. Clin Transl Allergy 2011;1:16.
  • 63
    Kotaniemi-Syrjanen A, Vainionpaa R, Reijonen TM, Waris M, Korhonen K, Korppi M. Rhinovirus-induced wheezing in infancy–the first sign of childhood asthma? J Allergy Clin Immunol 2003;111:6671.
  • 64
    Hyvarinen MK, Kotaniemi-Syrjanen A, Reijonen TM, Korhonen K, Korppi MO. Teenage asthma after severe early childhood wheezing: an 11-year prospective follow-up. Pediatr Pulmonol 2005;40:316323.
  • 65
    Malmstrom K, Pitkaranta A, Carpen O, Pelkonen A, Malmberg LP, Turpeinen M et al. Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms. J Allergy Clin Immunol 2006;118:591596.
  • 66
    Jartti T, Kuusipalo H, Vuorinen T, Soderlund-Venermo M, Allander T, Waris M et al. Allergic sensitization is associated with rhinovirus-, but not other virus-, induced wheezing in children. Pediatr Allergy Immunol 2010;21:10081014.
  • 67
    Edwards MR, Regamey N, Vareille M, Kieninger E, Gupta A, Shoemark A et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 2013;6:797806.
  • 68
    Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM et al. A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003;349:14141422.
  • 69
    Illi S, von Mutius E, Lau S, Niggemann B, Gruber C, Wahn U. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006;368:763770.
  • 70
    Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008;178:218224.
  • 71
    Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med 2010;181:315323.
  • 72
    Axelsson M, Brink E, Lundgren J, Lotvall J. The influence of personality traits on reported adherence to medication in individuals with chronic disease: an epidemiological study in West Sweden. PLoS ONE 2011;6:e18241.
  • 73
    Bel EH, Sousa A, Fleming L, Bush A, Chung KF, Versnel J et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011;66:910917.
  • 74
    Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011;127:355360.
  • 75
    Wenzel SE, Schwartz LB, Langmack EL, Halliday JL, Trudeau JB, Gibbs RL et al. Evidence that severe asthma can be divided pathologically into two inflammatory subtypes with distinct physiologic and clinical characteristics. Am J Respir Crit Care Med 1999;160:10011008.
  • 76
    Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, Fairs A et al. Fungi and allergic lower respiratory tract diseases. J Allergy Clin Immunol 2012;129:280291; quiz 292–283.
  • 77
    Denning DW, O'Driscoll BR, Hogaboam CM, Bowyer P, Niven RM. The link between fungi and severe asthma: a summary of the evidence. Eur Respir J 2006;27:615626.
  • 78
    Denning DW, O'Driscoll BR, Powell G, Chew F, Atherton GT, Vyas A et al. Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study. Am J Respir Crit Care Med 2009;179:1118.
  • 79
    Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control study. Am J Respir Crit Care Med 2004;170:836844.
  • 80
    Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M et al. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011;12:38.
  • 81
    Martin RJ, Szefler SJ, King TS, Kraft M, Boushey HA, Chinchilli VM et al. The Predicting Response to Inhaled Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 2007;119:7380.
  • 82
    Kerstjens HA, Disse B, Schroder-Babo W, Bantje TA, Gahlemann M, Sigmund R et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. J Allergy Clin Immunol 2011;128:308314.
  • 83
    Busse WW, Morgan WJ, Gergen PJ, Mitchell HE, Gern JE, Liu AH et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med 2011;364:10051015.
  • 84
    Pavord ID, Bush A. Anti-IgE for asthma in inner-city children. N Engl J Med 2011;364:25562557; author reply 2557–2558.
  • 85
    Wenzel S, Ford L, Pearlman D, Spector S, Sher L, Skobieranda F et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013;368:24552466.
  • 86
    Lommatzsch M, Korn S, Buhl R, Virchow JC. Against all odds: anti-IgE for intrinsic asthma? Thorax 2013, doi: 10.1136/thoraxjnl-2013-203738.
  • 87
    Wahidi MM, Kraft M. Bronchial thermoplasty for severe asthma. Am J Respir Crit Care Med 2012;185:709714.
  • 88
    Chishimba L, Niven RM, Cooley J, Denning DW. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization. J Asthma 2012;49:423433.
  • 89
    Bafadhel M, Clark TW, Reid C, Medina MJ, Batham S, Barer MR et al. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD. Chest 2011;139:14101418.
  • 90
    Akdis CA. Therapies for allergic inflammation: refining strategies to induce tolerance. Nat Med 2012;18:736749.
  • 91
    Lagerlov P, Veninga CC, Muskova M, Hummers-Pradier E, Stalsby Lundborg C, Andrew M et al. Asthma management in five European countries: doctors' knowledge, attitudes and prescribing behaviour. Drug Education Project (DEP) group. Eur Respir J 2000;15:2529.
  • 92
    Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J 2009;33:897906.
  • 93
    Clatworthy J, Price D, Ryan D, Haughney J, Horne R. The value of self-report assessment of adherence, rhinitis and smoking in relation to asthma control. Prim Care Respir J 2009;18:300305.
  • 94
    Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999: the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J 2000;16:802807.
  • 95
    Starren ES, Roberts NJ, Tahir M, O'Byrne L, Haffenden R, Patel IS et al. A centralised respiratory diagnostic service for primary care: a 4-year audit. Prim Care Respir J 2012;21:180186.
  • 96
    Heaney LG, Robinson DS. Severe asthma treatment: need for characterising patients. Lancet 2005;365:974976.
  • 97
    Pinnock H, Ostrem A, Rodriguez MR, Ryan D, Stallberg B, Thomas M et al. Prioritising the respiratory research needs of primary care: the International Primary Care Respiratory Group (IPCRG) e-Delphi exercise. Prim Care Respir J 2012;21:1927.
  • 98
    Haahtela T, Tuomisto LE, Pietinalho A, Klaukka T, Erhola M, Kaila M et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006;61:663670.
  • 99
    Bergeron C, Tulic MK, Hamid Q. Airway remodelling in asthma: from benchside to clinical practice. Can Respir J 2010;17:e85e93.
  • 100
    Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A et al. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med 2003;167:7882.
  • 101
    Saglani S, Molyneux C, Gong H, Rogers A, Malmstrom K, Pelkonen A et al. Ultrastructure of the reticular basement membrane in asthmatic adults, children and infants. Eur Respir J 2006;28:505512.
  • 102
    Saglani S, Malmstrom K, Pelkonen AS, Malmberg LP, Lindahl H, Kajosaari M et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722727.
  • 103
    Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE et al. A critical role for eosinophils in allergic airways remodeling. Science 2004;305:17761779.
  • 104
    Asher MI. Urbanisation, asthma and allergies. Thorax 2011;66:10251026.
  • 105
    Ellwood P, Asher MI, Beasley R, Clayton TO, Stewart AW. The international study of asthma and allergies in childhood (ISAAC): phase three rationale and methods. Int J Tuberc Lung Dis 2005;9:1016.
  • 106
    Vartiainen E, Petays T, Haahtela T, Jousilahti P, Pekkanen J. Allergic diseases, skin prick test responses, and IgE levels in North Karelia, Finland, and the Republic of Karelia, Russia. J Allergy Clin Immunol 2002;109:643648.
  • 107
    Juniper EF, Bousquet J, Abetz L, Bateman ED. Identifying ‘well-controlled’ and ‘not well-controlled’ asthma using the Asthma Control Questionnaire. Respir Med 2006;100:616621.
  • 108
    Pinnock H, Fletcher M, Holmes S, Keeley D, Leyshon J, Price D et al. Setting the standard for routine asthma consultations: a discussion of the aims, process and outcomes of reviewing people with asthma in primary care. Prim Care Respir J 2010;19:7583.
  • 109
    Gibson PG, Powell H, Coughlan J, Wilson AJ, Abramson M, Haywood P et al. Self-management education and regular practitioner review for adults with asthma. Cochrane Database Syst Rev 2003;(1):CD001117.
  • 110
    Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ 2005;330:644648.
  • 111
    Horne R, Price D, Cleland J, Costa R, Covey D, Gruffydd-Jones K et al. Can asthma control be improved by understanding the patient's perspective? BMC Pulm Med 2007;7:8.
  • 112
    Ostojic V, Cvoriscec B, Ostojic SB, Reznikoff D, Stipic-Markovic A, Tudjman Z. Improving asthma control through telemedicine: a study of short-message service. Telemed J E Health 2005;11:2835.
  • 113
    van der Meer V, Bakker MJ, van den Hout WB, Rabe KF, Sterk PJ, Kievit J et al. Internet-based self-management plus education compared with usual care in asthma: a randomized trial. Ann Intern Med 2009;151:110120.
  • 114
    Jan RL, Wang JY, Huang MC, Tseng SM, Su HJ, Liu LF. An internet-based interactive telemonitoring system for improving childhood asthma outcomes in Taiwan. Telemed J E Health 2007;13:257268.
  • 115
    Ryan D, Price D, Musgrave SD, Malhotra S, Lee AJ, Ayansina D et al. Clinical and cost effectiveness of mobile phone supported self monitoring of asthma: multicentre randomised controlled trial. BMJ 2012;344:e1756.